(PRESS RELEASE) COURBEVOIE, 10-Jan-2023 — /EuropaWire/ — Saint-Gobain (EPA: SGO), a French multinational producer of construction, high-performance, and other materials, has announced the successful completion of a bond issue of 1.15 billion EUR. The bond issue was split into two … Read the full press release
Posted in Business, Chemicals, Construction, Financial, France, Investment
Tagged 1.15 billion EUR, 18-month maturity, 2.5 times, 3 months Euribor +0.20%, 3.50%, 6-year maturity, Bond issue, construction, credit quality, debt maturities, favorable market conditions, financing costs, fixed rate note, floating rate note, funding, investor support, investors, long-term, optimism, oversubscribed, refinancing, Saint-Gobain, tranches
(PRESSEMITTEILUNG) COURBEVOIE, 10-Jan-2023 — /EuropaWire/ — Saint-Gobain (EPA: SGO), ein französischer multinationaler Hersteller von Bau-, Hochleistungs- und anderen Materialien, hat den erfolgreichen Abschluss einer Anleiheemission in Höhe von 1,15 Mrd. EUR bekannt gegeben. Die Anleihe wurde in zwei Tranchen aufgeteilt, … Read the full press release
Posted in Business, Chemicals, Construction, Financial, France, Investment
Tagged 1, 15 Mrd. EUR, 18 Monate Laufzeit, 2, 20 %, 3, 3 Monate Euribor +0, 5-fach, 50 %, 6 Jahre Laufzeit, Anleiheemission, Bau, Bonität, Finanzierung, Finanzierungskosten, fixed rate note, floating rate note, Fremdkapitallaufzeiten, günstige Marktbedingungen, Investoren, Investorenunterstützung, langfristig, Optimismus, Refinanzierung, Saint-Gobain, Tranchen, überzeichnet
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
